Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward
Open Access
- 19 May 2020
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 5 (47)
- https://doi.org/10.1126/sciimmunol.abc6347
Abstract
Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual level versus population level).Keywords
This publication has 11 references indexed in Scilit:
- Antibody testing will enhance the power and accuracy of COVID-19-prevention trialsNature Medicine, 2020
- Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic periodScience, 2020
- Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implicationsPublished by Cold Spring Harbor Laboratory ,2020
- Performance Characteristics of a Multiplex Flow Immunoassay for Detection of IgG-Class Antibodies to Measles, Mumps, Rubella, and Varicella-Zoster Viruses in Presumptively Immune Health Care WorkersJournal of Clinical Microbiology, 2020
- Viral Kinetics and Antibody Responses in Patients with COVID-19Published by Cold Spring Harbor Laboratory ,2020
- Dengue pre-vaccination screening and positive predictive valuesThe Lancet Infectious Diseases, 2019
- Integrated Serologic Surveillance of Population Immunity and Disease TransmissionEmerging Infectious Diseases, 2018
- Use of serological surveys to generate key insights into the changing global landscape of infectious diseaseThe Lancet, 2016
- Estimating Prevalence Using an Imperfect TestEpidemiology Research International, 2011
- Basic Methods for Sensitivity Analysis of BiasesInternational Journal of Epidemiology, 1996